SCHEMBL3584713

SCHEMBL3584713

O=C(Nc1cc(F)cc(F)c1)Nc1ccc(-c2ccc(C(F)(F)F)cc2)cc1-c1nnn[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 1/20 0.41
KIF11 P52732 1/20 0.41
PLK4 O00444 1/20 0.40
KDR P35968 7/20 0.39
FLT3 P36888 4/20 0.39
RIPK1 Q13546 2/20 0.39
NTRK1 P04629 1/20 0.39
RET P07949 1/20 0.39
PDGFRB P09619 1/20 0.39
LTK P29376 1/20 0.39
CDK8 P49336 1/20 0.39
NTRK3 Q16288 1/20 0.39
MAPK14 Q16539 1/20 0.39
NTRK2 Q16620 1/20 0.39
AURKB Q96GD4 1/20 0.39
KIT P10721 3/20 0.39
ABL1 P00519 2/20 0.39
LCK P06239 2/20 0.39
FYN P06241 2/20 0.39
CSF1R P07333 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3579491 0.92 PSEN1 (0.47) KIF11PLK4KDRFLT3RIPK1
SCHEMBL3576183 0.91 KDR (0.44) KIF11PLK4KDRFLT3RIPK1
SCHEMBL3580763 0.90 PSEN1 (0.45) PLK4KDRFLT3RIPK1NTRK1
SCHEMBL3581506 0.89 MAPT (0.43) KIF11KDRFLT3RIPK1NTRK1
SCHEMBL3573189 0.88 CNR1 (0.43) PLK4KDRFLT3NTRK1PDGFRB
SCHEMBL3579750 0.87 DGAT1 (0.42) KDRFLT3KITABL1IGF1R
SCHEMBL3577053 0.87 KDR (0.51) PLK4KDRFLT3NTRK1RET
SCHEMBL3576165 0.87 GRIK1 (0.48) KDRFLT3NTRK1RETPDGFRB
SCHEMBL3584463 0.87 KDR (0.47) KIF11KDRFLT3RIPK1NTRK1
SCHEMBL3581070 0.86 KIF11 (0.48) KIF11KDRFLT3RIPK1NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293553-A1 Diphenylurea Derivatives Useful As Potassium Channel Activators NEUROSEARCH A/S (DK) 2007-12-20 US claimed
US-20060178413-A1 Diphenylurea derivatives and their use as chloride channel blockers NEUSEARCH A/S (DK) 2006-08-10 US claimed
US-7691891-B2 Diphenylurea derivatives and their use as chloride channel blockers NEUROSEARCH A/S (DK) 2010-04-06 US disclosed
US-20070293553-A1 Diphenylurea Derivatives Useful As Potassium Channel Activators NEUROSEARCH A/S (DK) 2007-12-20 US disclosed
US-20060178413-A1 Diphenylurea derivatives and their use as chloride channel blockers NEUSEARCH A/S (DK) 2006-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293553-A1 Diphenylurea Derivatives Useful As Potassium Channel Activators KCNJ2, KCNH2, KCNH3 MTOR 4152/4885KIF11 2164/4885PLK4 2967/4885
US-20060178413-A1 Diphenylurea derivatives and their use as chloride channel blockers CLIC1, CLIC4, CLCN2 MTOR 3717/4885KIF11 3676/4885PLK4 3847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.